Recognizing ADHD: Neurobiology, Symptoms, and Treatment
Thomas E. Brown, PhD Assistant Clinical Professor of Psychiatry Yale University School of Medicine Yale-New Haven Hospital New Haven, Connecticut
There is no charge for participating in this educational activity. Term of Offering:  CME credit for this archived Internet webcast program will be available through September 1, 2002. The original release of this material was June7th, 2001. CME credit is offered upon successful completion of the post-test.

Faculty Biography Thomas E. Brown, PhD Dr. Thomas E. Brown is assistant clinical professor of psychiatry at the Yale School of Medicine and associate director of the Yale Clinic for Attention and Related Disorders in Adults. He has a comprehensive clinical background in the area of ADHD and has attained many prestigious honors for his work in the study and treatment of this disease, including induction into the CHADD Hall of Fame. Dr. Brown is a member of the professional advisory board of the NADDA, and is a respected author of numerous publications in the area of ADHD.

Back to Top

Learning Objectives

After completion of this program, participants should be able to:

• Describe the wide variety of ADHD-related impairments
• Describe “executive functions” and their manifestations in patients with ADHD
• Outline appropriate treatment interventions for patients with ADHD based on its neurobiological etiology and on diagnostic criteria

Back to Top

Faculty Disclosure

Thomas E. Brown, PhD 
Formal advisor: Eli Lilly and Company; Novartis Pharmaceuticals Corporation; Shire Richwood Inc.; Alza Pharmaceuticals. Researcher: Glaxo Wellcome Inc.; Cephalon, Inc.; SmithKline Beecham. Speakers’ bureau: Glaxo Wellcome Inc.; Novartis Pharmaceuticals Corporation; Eli Lilly and Company; Shire Richwood Inc. Financial interest: The Psychological Corporation®; American Psychiatric Press, Inc.

Back to Top